Itay & Beyond

Itay & Beyond

Private
Tel AvivHealthcare & Life Scienceshttps://itayandbeyond.com/

Last Round

Pre Seed

Nov 25, 2025

Total Funding Raised

$1.91M

Company Overview

Itay & Beyond is a biotechnology company that provides a drug discovery platform combining brain organoids with AI analysis to predict the efficacy of drugs for neurological and psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discovery platformbrain organoidsbrain-on-a-chipAI drug discoverydrug efficacy predictionmini brainsCNS drug discoveryorgan-on-a-chipelectrophysiology readoutspatient-derived organoidsanimal model alternativesclinical trial de-riskingneurotechpreclinical modelsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Itay & Beyond Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Itay & Beyond Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedNov 25, 2025

Key People

Founding team and executive leadership

Nisim Perets

Co-Founder And CEO

Founding Team

Itay & Beyond Investors

Notable investors and investment history

InvestorRounds
Living Hope VCPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 25, 2025

    $1.9M round led by Living Hope VC

  • Jun 2, 2025

    Grew 23% QoQ, from 13 to 16 employees.

Itay & Beyond Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Itay & Beyond Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Itay & Beyond's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range15
Year Founded2021
Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.